Behavioral and Psychosomatic Medicine
Behavioral and Psychosomatic Medicine in the Columbia University Department of Psychiatry is comprised of two divisions: Behavioral Medicine, which is primarily a research division, and Consultation-Liaison (C-L) Psychiatry, which is predominantly a clinical service serving NewYork-Presbyterian Hospital.
- To understand the contribution of psychological, psychosocial, and behavioral factors to the onset, progression, and management of physical and mental disease
- To identify the relevant pathophysiological mechanisms linking psychological states to disease
- To develop treatment interventions targeting these mechanisms
Our research addresses the contribution of psychological, psychosocial, and behavioral factors to the onset, progression, and management of physical and mental disease; identifies the relevant pathophysiological mechanisms linking psychological states to disease; and develops interventions targeting these mechanisms. Projects range from societal to subcellular levels:
- Studying the role the autonomic nervous system plays as a candidate mechanism linking psychological characteristics of depression and hostility to the pathophysiology of coronary artery disease
- Integrating the fields of psychopathology, developmental psychobiology, and perinatal psychiatry to focus on the earliest influences on children’s developmental trajectories—those that happen in utero—and how to intervene early to prevent mental health problems
- Combining basic biology, neuroscience, stress physiology, and mitochondrial medicine to explore conserved organizing principles of mitochondrial signal transduction, and examine the underlying mechanisms operating across levels of complexity from organelle to organism
Programs and Centers
The mission of the C-L Service is to address the psychiatric issues of medical and surgical in- and out-patients at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and affiliated clinics. Faculty and trainees pursue research and scholarship in several related domains, often in collaboration with colleagues in the Division of Behavioral Medicine and other research groups within the Department of Psychiatry. Our overarching goal is to improve care and outcomes for psychiatric and psychological problems co-morbid with or presenting as somatic disorders.
Recent studies have examined a broad range of topics encompassed within this overarching goal. These include:
- The association of psychiatric and social history with adherence and morbidity in stem cell transplant patients
- Ethical and psychosocial factors affecting wellbeing for patients with sickle cell anemia
- Psychosocial factors affecting the use of HIV pre-exposure prophylaxis
- Substance use disorders in liver transplant patients
- Implementation of telepsychiatry consultation
- Psychiatric morbidity of COVID-19
- Promoting resilience and wellness in hospital staff
- Access to high-quality end-of-life care for individuals with mental illness
The Early Neuroimaging, Neuroimmune, and Neuropsychology Lab (Early N3 Lab) aims to identify early immune, brain, and neuropsychological antecedents of childhood psychiatric risk to reduce the time to intervention for young children.
The Perinatal Pathways Lab conducts research studies with pregnant women and their babies to improve their well–being and their future children’s lives.
The Mitochondrial Signaling Laboratory conducts research that enhances the understanding of mind-body interactions.